A series of N-substituted pyrazole derivatives have been synthesized and tested for their anticancer effect on the HL-60 leukaemia cell line. Four were active both in cell-growth inhibition and in inducing apoptosis. The inhibition of cell growth mainly reflects a compound-induced reduction in the number of cells in phases from S to M, whereas the induction of apoptosis involves inhibition of expression of Bcl-2 and enhanced expression of Bax with consequent reduced activation of the proapoptotic caspase 3. Finally, preliminary experiments carried out with tumor cells from myelogenous leukaemic patients showed that the compounds 4c, 4l, 4m, and 4n are indeed capable of inducing apoptosis
AbstractWe designed new pyrazole derivatives as inhibitors of the cell cycle kinases and developed a...
In search of synthetic chemotherapeutic substances capable of inhibiting, retarding, or reversing th...
Leukemia is a particular type of cancer characterized by the failure of cell death or disability in ...
A series of N-substituted pyrazole derivatives have been synthesized and tested for their anticancer...
Pyrazole moiety is one of the main scaffold for many anticancer drug candidates.Many pyrazole deriva...
We report here the synthesis of new pyrazolo[3,4-d]pyrimidine derivatives along with their biologica...
We report here the synthesis of new pyrazolo[3,4-d]pyrimidine derivatives along with their biologica...
A new series of pyrazoline derivatives 1b–12b was designed, synthesized and evaluated for antiprolif...
New pyrazoline derivatives were synthesized and evaluated for their cytotoxic effects on AsPC-1 huma...
A series of forty different pyrazole containing benzimidazole hybrids (6e45) have been designed, syn...
As part of our continuing search for potential anticancer drug candidates in YC-1 analogs, several 1...
New pyrazole derivatives were designed and synthesized as potential protein kinase inhibitors in the...
A series of highly functionalized pyrazole derivatives has been prepared by a one-pot, versatile and...
Pyrazole moiety represents an important category of heterocyclic compound in pharmaceutical and medi...
A series of pyrazolo-triazole hybrids were designed and synthesized by combining the 1,3-diphenyl py...
AbstractWe designed new pyrazole derivatives as inhibitors of the cell cycle kinases and developed a...
In search of synthetic chemotherapeutic substances capable of inhibiting, retarding, or reversing th...
Leukemia is a particular type of cancer characterized by the failure of cell death or disability in ...
A series of N-substituted pyrazole derivatives have been synthesized and tested for their anticancer...
Pyrazole moiety is one of the main scaffold for many anticancer drug candidates.Many pyrazole deriva...
We report here the synthesis of new pyrazolo[3,4-d]pyrimidine derivatives along with their biologica...
We report here the synthesis of new pyrazolo[3,4-d]pyrimidine derivatives along with their biologica...
A new series of pyrazoline derivatives 1b–12b was designed, synthesized and evaluated for antiprolif...
New pyrazoline derivatives were synthesized and evaluated for their cytotoxic effects on AsPC-1 huma...
A series of forty different pyrazole containing benzimidazole hybrids (6e45) have been designed, syn...
As part of our continuing search for potential anticancer drug candidates in YC-1 analogs, several 1...
New pyrazole derivatives were designed and synthesized as potential protein kinase inhibitors in the...
A series of highly functionalized pyrazole derivatives has been prepared by a one-pot, versatile and...
Pyrazole moiety represents an important category of heterocyclic compound in pharmaceutical and medi...
A series of pyrazolo-triazole hybrids were designed and synthesized by combining the 1,3-diphenyl py...
AbstractWe designed new pyrazole derivatives as inhibitors of the cell cycle kinases and developed a...
In search of synthetic chemotherapeutic substances capable of inhibiting, retarding, or reversing th...
Leukemia is a particular type of cancer characterized by the failure of cell death or disability in ...